Trial Profile
Clinical Trials Insight: 700037610
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2008
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Sponsors Sorin Group
- 01 Oct 2008 New trial record.